Live from the NIH registry
Studies recruiting near Palm Bay right now
Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: US Oncology Research
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Cancer Care Centers of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: Akero Therapeutics, Inc
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
Phase 3
Interventional 558 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: BioNTech SE
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Neovascular Age-Related Macular Degeneration
Phase 3
Interventional 1,000 participants sought
Florida Eye Associates — Melbourne, Florida (8.9 mi)
· Sponsor: Hoffmann-La Roche
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Melbourne, Florida (8.9 mi)
· Sponsor: GlaxoSmithKline
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Phase 3
Interventional 400 participants sought
Vero Beach Neurology — Vero Beach, Florida (27.6 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - 007-926-C — Vero Beach, Florida (27.6 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Seaport Therapeutics
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Cancer Care of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: Summit Therapeutics
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Melbourne, Florida (8.9 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
New Vision Eye Center /ID# 269955 — Vero Beach, Florida (27.6 mi)
· Sponsor: AbbVie
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Melbourne, Florida (8.9 mi)
· Sponsor: Alnylam Pharmaceuticals
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 850 participants sought
Neurocrine Clinical Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Neurocrine Biosciences
The Preeclampsia Registry
Preeclampsia, Eclampsia
N/A
Observational 20,000 participants sought
Preeclampsia Foundation — Melbourne, Florida (8.9 mi)
· Sponsor: Preeclampsia Foundation
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: Pfizer
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Breast Cancer
Phase 3
Interventional 625 participants sought
Research Site — Palm Bay, Florida (6.5 mi)
· Sponsor: AstraZeneca
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 74 participants sought
Research Site — Melbourne, Florida (8.9 mi)
· Sponsor: Maze Therapeutics
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
Florida Cancer Specialists — Vero Beach, Florida (27.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: Gilead Sciences
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2, Phase 3
Interventional 650 participants sought
Site #0136 — Palm Bay, Florida (6.5 mi)
· Sponsor: Bicara Therapeutics
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Small-cell Lung Cancer
Phase 3
Interventional 480 participants sought
Cancer Centers of Bevard — Rockledge, Florida (27.1 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Apollo Surgery Center — West Melbourne, Florida (7.5 mi)
· Sponsor: Stryker Instruments
Clinical Trial on Agitation in Alzheimer's Dementia
Alzheimer Disease, Agitation,Psychomotor
Phase 2
Interventional 164 participants sought
ClinCloud, LLC — Melbourne, Florida (8.9 mi)
· Sponsor: IGC Pharma, LLC